D. Piancatelli et al., DETECTION OF CIRCULATING ICAM-1 AND SOLUBLE IL-2 RECEPTOR IN SERUM OFCOLORECTAL-CANCER PATIENTS, International journal of immunotherapy, 10(1), 1994, pp. 15-20
Malignancies are often associated with alterations of some immunologic
al parameters. The evaluation of soluble molecules in serum is an impo
rtant non-invasive approach in order to verifty the immune condition o
f cancer patients. Recently, alterations of soluble interleukin-2 rece
ptor (sIL-2R) production have been observed in neoplastic diseases. In
this study, serum levels of sIL-2R and circulating intercellular adhe
sion molecule-1 (clCAM-1) were assessed, using enzyme immunological te
sts (ELISA), in 38 patients with colorectal cancer at diagnosis and 32
healthy subjects. No difference in clCAM-1 levels was found; a statis
tically significant increase of sIL-2R was found in colon cancer patie
nts (p < 0.0001). No correlation of sIL-2R with stage of the disease a
nd other histopathologic parameters was found. A significant correlati
on was found between clCAM-1 and histologic grading of tumour cell dif
ferentiation and between sIL-2R and clCAM-1. These data suggest that i
n colorectal adenocarcinoma sIL-2R may be important in the pathogenesi
s of immune alterations associated with tumour progression.